Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. 5e. TASK NUMBER 5f. WORK UNIT NUMBER
Introduction
The funding for this project is comprised of two components. The first component, which represents 95% of the funding, is dedicated to filling out shell space in Othmer Hall, the home for the Biological Process Development Facility. The other 5% is dedicated to research focused on the expression of antibodies against the botulinum neurotoxins in Chinese Hamster Ovary (CHO) cells. This report will provide a summary of May 2004 -August 2006 activities, which includes the design of a scaled-down Current Good Manufacturing Practice (CGMP) facility for yeast and bacteria at the 150 L working volume bioreactor scale and mammalian cell culture research of a chimeric full-length antibody against serotype A and methods to screen transformed mammalian clones. The report is structured with the first part describing the construction and design activities followed by three separate reports the describe cell culture research activities.
Body

Construction Project cGMP Construction Project
On December 2003 the University Of Nebraska Board Of Regents (BOR) approved the CGMP basement project, which included conceptual design to bid documents. During this process it became apparent that building the processing suites in the basement was not the preferred option. The design was changed to include the processing space of the CGMP facility on the first floor of Othmer Hall and the raw material storage and the CGMP utilities in the basement of Othmer Hall. A sketch of the first floor ( Figure 1 ) and basement ( Figure 2 ) are presented below. The intent is to use modular clean rooms for the CGMP processing space and a majority of our existing CGMP processing equipment in this facility. As per University requirements, this new design proposal must be submitted to the University of Nebraska Board of Reagents for approval and is scheduled for the November 2006 BOR meeting.
The CGMP facility will have the following capabilities:
Fermentation Suite: 150 L working volume fermentor for yeast and bacteria, harvesting and clarifying capabilities using either continuous centrifugation or cross flow membrane filtration and cell disruption.
Purification Suite: 0.1 to 6 L/min chromatography skid and two ultrafiltration systems.
Asceptic Processing Suite:
Isolator system with a VHP (vaporized hydrogen peroxide) unit for sterilization capable of producing Master and Working Cell Banks and manual filling of upto 1500 liquid vials.
First Floor Support Space: Dirty staging, clean staging, buffer prep, and gowning.
Basement Support Space: Pure steam generator, pure steam condenser to produce water for injection (WFI), WFI storage tank, water treatment system (softener and reverse osmosis system) for the pure steam generator, Clean-InPlace system, and WFI distribution system. Included are room temperature and cold room storage for released and quarantined raw materials, final product release and quarantine storage (4 o C and -80 o 
C).
It is anticipated that upon approval it will take approximately 12 months to build and an additional 3 to 5 months to validate. If fully approved in November 2006, the project will start first quarter 2007. 
Monoclonal Antibody Research Project
Construction of pG6-GFP-Zeo for expression of light and heavy chains of S25 Antibody.
Introduction
Botulinum neurotoxins (BoNTs) are listed as one of the 6 highest risk threats for bioterrorism by the Centers for Disease Control (CDC) due to their potency, lethality, and ease of production. Botulinum neurotoxin is expressed in the bacteria Clostridium botulinum and is one of the most poisonous substances known. The large scale production of humanized monoclonal antibodies (huMabs) with neutralizing activity against toxins (i.e. botulinum neurotoxin)
has been identified as one of the highest priorities to counter bioterrorism as drugs for the treatment of botulism are currently unavailable. Recently, potent neutralizing monoclonal antibodies against botulinum neurotoxin serotype A (BoNT/A) were identified, characterized and further cloned to yield humanized Mabs against BoNT/A. In our previous published study, we produced S25 antibody against botulinum neurotoxin serotype A (BoNT/A). However,
procedures to obtain stable cell lines are lengthy and the plasmids are not easily applicable for any antibody production. Our overall goal is to develop a mammalian expression system that can be used for production of humanized antibodies and to develop and optimize a production strategy for the large scale production of the antibody based therapeutics for countering BoNT and other agents of biowarfare and bioterrorism. To achieve these objectives, we constructed an expression vector that the heavy and light chains of any antibody could be sub-cloned in two steps. Selection with a dual selectable marker and subsequent screening based on Green Fluorescence Protein (GFP) decreased the number of clonal cell lines that needed to be screened, and allowed for isolation of an optimized production cell lines. Once this strategy was proven to work for S25 antibody production, we have then constructed general plasmids that can be utilized for any antibody production in CHO cell lines. Outline of these experiments and resulting plasmids are given in the experimental procedures section of this report.
Experimental Procedures
Starting with the original plasmid of pcDNA3.1 (+) (Invitrogen) ( Fig. 1) , the experimental steps to construct the general expression vector pG6-GFP-Zeo and the cloning of the heavy and light chains of S25 antibody in this plasmid to obtain pG9-GFP-Zeo is given below. All PCR performed with Hot Star Pfu Turbo (Stratagene) DNA polymerase. All ligations were performed using Quick Ligation kit (Bio-lab laboratories). Fig. 3) and inserted SV40, MCS fragment into this Plasmid, upstream of β-globin promoter in pG4 pG3/TKpA/MCS.SV40pA/CMV (pG6) PCR amplification of fragment CMV from pcDNA 3.1(+) and cut pG5 with Bgl II and inserted this (see Fig. 4 
Construction of PG6-GFP-Zeo Plasmids
To decrease the time and effort required to isolate high expressing gene amplified cell lines, we constructed the plasmid pG6-GFP and pG9-GFP (see Fig. 6 and 7), containing GFP-zeocin. It took 6 steps (see at the above) to construct of pG6. This plasmid contains two CMV promoters and two different multiple cloning sites for the insertion of the light and heavy chain. It also contains dhfr driven by a β-globin promoter and 3 different polyadenylation sites. 
ABSTRACT
Isolation and selection of mammalian cell lines with high antibody production is one of the most critical and laborious steps in obtaining a high yielding cell culture process. Selection with a dual selectable marker and subsequent screening based on GFP fluorescence could decrease the number of clonal cell lines that need to be screened, and allow for the isolation of an optimized production cell line. CHO-DG44 cells were transfected with a plasmid (pS25-gfp) containing dual selectable markers, gfp-zeocin fusion and dhfr. Cells selected based on dhfr and zeocin showed a large increase in antibody production in comparison to cells selected based on dhfr or zeocin alone.
Fifty-five percent of the cells selected showed antibody titers of greater than 1 µg/ml in comparison to less than 5% using either zeocin or dhfr alone. After three days in adherent culture, a cell line selected using both selectable markers produced 27 µg/ml S25 antibody and had a specific productivity of 15 pg/cell/day. The highest producing clone obtained using dhfr or zeocin alone resulted in a specific productivity of 3.1 pg/cell/day. To confirm that a high producing production cell line could be obtained the cells were transferred to suspension culture and were grown in both batch and fed-batch culture. An antibody concentration of 74 µg/ml was obtained after 6 days in batch culture, while 250 µg/ml was obtained in fed-batch culture. These correspond to specific antibody productivities of 5 and 15 pg/cell/day, respectively. These results show that a dual selectable marker can be used to obtain a high producing production cell line and further improvements could be obtained by selection based on GFP fluorescence.
INTRODUCTION
Production of therapeutic monoclonal antibodies and antibody derivatives constitutes 20% of the biopharmaceutical products in development (Roque, et al. 2004 ). These antibody products are typically produced in mammalian cells such as Chinese Hamster Ovary (CHO) and NS0, a mouse myeloma derived cell line. To obtain a stable antibody producing cell line, cells are transfected with a plasmid or plasmids containing the light and heavy chain genes along with a selectable marker, such as an antibiotic resistance gene. Since a wide range of antibody productivities is achieved in the transfected population, a single cell clone is usually selected in order to obtain a culture with high monoclonal antibody productivity.
Various methods have been used to obtain cells with high productivities. These include the use of an amplification strategy using dihydrofolate reductase (dhfr) in CHO cells (Alt, et al., 1978; Urlaub and Chasin, 1980) and glutamine synthetase (GS) in NS0 (Cockett et al., 1990; Bebbington et al., 1992) . Selection at increasing concentrations of methotrexate (MTX) in the case of dhfr, or methionine sulfoximine (MSX) for GS results in an increase in amount of integrated DNA and more importantly an increase in antibody or protein expression. The efficiency and stability of gene amplification is dependent on the location of insertion in the chromosomal DNA in the selected clone (Kim et al., 1998; Yoshikawa et al., 2000) .
In addition to gene amplification, several methods of improved clonal selection have been employed. Meng et al. (2000) used green fluorescent protein (GFP), along with dhfr, as a second selectable marker for the isolation of CHO DXB11 cells with high protein expression. NT3, DNase or VEGF, along with dhfr, were expressed from a single SV40 promoter contruct separated by an internal ribosomal entry site (IRES), while GFP was produced from a second SV40 promoter. Protein productivity corresponded well with GFP fluorescence. In addition, a single clone with high VEGF production was isolated by selection only for GFP fluorescence by flow cytometry. FACS sorting produced a clone with a specific productivity of 4.4 pg/cell/day compared to 0.7 pg/cell/day selected by dilution cloning alone.
To obtain a clone with high antibody productivity, a plasmid was constructed for the production of the light and heavy chains of a chimeric antibody against botulinum neurotoxin serotype A. In addition to the light and heavy chain fragments, the plasmid contained dhfr and a gfp/zeocin fusion protein for selection of stable clones. Selection on dhfr and/or zeocin were used and GFP production was correlated with antibody production. It is suggested that two selectable markers on a single expression plasmid may allow for greater clonal selection and stability than a single selectable marker. GFP was included in order to quickly analyze numerous clones after the initial selection procedure.
MATERIALS AND METHODS
Contruction of plasmid vectors
CHO-DG44 cells, obtained from Dr. Larry Chasin (Columbia University), were maintained in α-MEM media containing 8% fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA). To construct the pS25-GFP plasmid 
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ELISA
The concentration of the S25 antibody produced against botulinum neurotoxin serotype A was determined using an enzyme-linked immunosorbent assay. Botulinum neurotoxin serotype A H C (BoNTA H C ) fragment was previously produced and purified from Pichia pastoris in our lab. BoNTA H C was diluted to 5 µg/ml in coating buffer (100 mM NaHCO 3 , 100 mM NaCL, pH 9.3). One hundred µl diluted BoNTA H C was added to 96 well plates plates were incubated for 1 h at 37 o C, followed by the washing. The S25 antibody was detected by adding 100 µl of 1 mg/ml ABTS in ABTS buffer (Roche Applied Science, Indianapolis, IN). The absorbance was determined using an ELx800 plate reader (Bio-Tek, Winooski, VT) at 405 nm after incubating with shaking for 30 min at room temperature.
Flow Cytometry
CHO-DG44 cells were analyzed for GFP production using a FACScan flow cytometer (Becton-Dickinson, San Jose, CA). Cells were trypsinized using 0.25% trypsin in HBSS and resuspended in α-MEM media containing 8% FBS. Cells were then centrifuged at 300 x g and resuspended in an equal volume of PBS. The relative fluorescence intensity of approximately 10,000 cells per sample was determined.
Growth of CHO-DG44 S25-gfp cells in suspension culture
The CHO-DG44 pS25-gfp cells were transferred to suspension culture in IS-CHO-V (Irvine Scientific) media by slowly decreased FBS content in spinner flasks. Cells were initially seed at 3 x 10 5 cells/ml in 50 ml IS-CHO-V with 1 % FBS. Cells were fed every 2-4 days with slowly decreasing levels of FBS. Cells were frozen and stored in liquid nitrogen after approximately 10-12 passages. For the batch runs, cells were taken for frozen stock and allowed to grow for 3-5 passages and were seeded in IS-CHO-V media at 2.2 x 10 5 cells/ml in IS-CHO-V media. Cell counts were determined using a hemacytometer and S25 antibody production was analyzed by ELISA.
Growth of CHO-DG44 S25-gfp cells in fed-batch culture
CHO-DG44 pS25-gfp cells were grown in 25 ml Wheaton spinner flasks to obtain cells for fed-batch culture. Cells were seeded at 2 x 10 5 or 1 x 10 6 cells/ml in 220 ml IS-CHO-V media supplements with glutamine and amino acids in a 1 L controlled spinner flask. The pH, dissolved oxygen (DO) and temperature were controlled using a Cellferm-Pro control system (DAS-GIP, Julich, Germany). The pH was controlled by the addition of CO2 and 0.5 M sodium bicarbonate. The glucose was controlled at 2 mg/L by the addition of a 30 mg/ml glucose solution. A second feed solution consisted of 3 mM glutamine in IS-CHO-V media supplemented with 10 x MEM essential and 10 x MEM non-essential amino acids (Invitrogen). The total amino acid concentration in the feed media was 46 mM including glutamine. The glutamine concentration was maintained at 0.5 mM. Glucose and glutamine concentrations were determined using a Bioprofile 400 analyzer (Nova Biomedical, Waltham, MA).
RESULTS AND DISCUSSION
Analysis of CHO DG44 cells transfected with pS25-gfp plasmid
CHO-DG44 cells were transfected with the pS25 plasmid and stable cells were isolated in selection media.
Selection media consisted of α-MEM media containing ribonucleotides and deoxyribonucleotides (α-MEM(+)) supplemented with 400 µg/ml zeocin, α-MEM media lacking ribonucleotides and deoxyribonucleotides (α-MEM(-)), or α-MEM(-) media supplemented with 400 µg/ml zeocin. The three selection medias selected for stable transfectants based on zeocin alone, dhfr alone, or both zeocin and dhfr, respectively. Each of the selection media were supplemented with 8% FBS. Single cell populations were isolated by dilution cloning at 0.5 cells/well in a 96 well plate. The transfected cells were allowed to grow for 14 days and the S25 antibody production was determined by ELISA. Resulted showed that very few cells selected based on zeocin alone or dhfr alone resulted in stable clones with high S25 antibody productivity ( Figure 2 ). Three out of 40 cells isolated in zeocin had an antibody concentration greater than 0.5 µg/ml, with one having an antibody concentration of 2 µg/ml. Eighty clones isolated based on dhfr never showed an antibody concentration greater than 0.5 µg/ml, although a clone with a final antibody concentration of 2.3 µg/ml was previously obtained with a similar plasmid (pS25) (Mowry, et al., 2004) . This plasmid was similar to the pS25-gfp plasmid, except the gfp-zeocin selectable marker was replaced with G418. This cell line (CHO-DG44 pS25 #56) provided a specific antibody productivity of 3.1 pg/cell/day. In comparison, 55% of 82 cells isolated using both α-MEM(-) and zeocin for selection resulted in a antibody concentration of greater than 1 µg/ml (Figure 2 ). This improvement in selection significantly reduces the number of clones that need to be analyzed to obtain the final production cell line. The S25 antibody concentration obtained 14 days after cloning was further analyzed in the cultures selected in the presence of α-MEM(-) and zeocin. Twenty-three percent of the clones had a final antibody concentration of 1-5 µg/ml, 15% resulted in a concentration of 5-10 µg/ml, 10% resulted in a concentration of 10-20 µg/ml and 5% resulted in an antibody concentration of greater than 20 µg/ml.
Analysis of S25 antibody production and GFP fluorescence
Fifteen CHO-DG44 pS25-gfp cell lines were analyzed for GFP fluorescence using a Becton-Dickenson These combined results show that cell lines with increased antibody production can be obtained by using dual selectable markers followed by flow cytometery to measure GFP to further isolate clones with high GFP production and antibody production.
It should be noted that the gfp gene does not have to be on the same expression unit as the gene product of interest, in this case the S25 antibody. 
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Introduction
Botulinum neurotoxin (BoNTA) produced by the anaerobic bacteria Clostridium botulinum is one of the most potent toxins known to humans (1, 2). The active neurotoxin contains two polypeptide chains, heavy chain (100KDa) and light chain (50KDa) connected via a disulfide linkage (3, 4) . Recombinant monoclonal antibodies (mAb) could provide unlimited supply of antitoxin free of infectious disease risk neutralizing deadly toxins with out requiring human donors for plasmapheresis (5) . Recently, potent neutralizing monoclonal antibodies against botulinum neurotoxin serotype A (BoNTA) were identified, characterized, cloned and expressed in Chinese Hamster
Ovary (CHO) cells to yield humanized mAb's against BoNTA (6).
The suspension culture based manufacturing process has become the method of large-scale, commercial production of therapeutically important proteins from rCHO cells (7) . It is desirable to use serum-free media in suspension culture because serum can cause problems in the subsequent processes (8, 9) . However there is no universal serum free media applicable to all cell lines, specific media suitable for each cell line need to be developed (10, 11) .
The media used for an animal cell culture are very complex and the significance of particular compounds for cell growth or product synthesis is difficult to realize, therefore statistical methods are adopted to develop animal cell culture media. The traditional one factor at a time approach to optimization is time-consuming and incapable of reaching the true optimum especially because of interactions among the factors. Moreover, it assumes that the various growth parameters do not interact and the process response is a direct function of the single varied parameter (12, 13) . In contrast, the observed behavior of growth results from the interactive influences of the various variables (14) . Unlike conventional optimization, statistical optimization methods can take into account the interactions of variables in generating the process response. Response surface methodology (RSM), an experimental strategy for seeking the optimum conditions for a multivariable system, described first by Box and Wilson, is a much more efficient technique for optimization (15) . RSM consists of a group of mathematical and statistical procedures that can be used to study relationships between one or more responses and a number of independent variables. In addition to analyzing the effects of independent variables, this experimental methodology generates a mathematical model that accurately describes the overall process (16, 17) . Recently RSM has been employed to solve the multivariate problems and optimize several responses in many types of experimentation (18, 19, 20) . In this approach, concentrations of medium components are the variables; each variable is referred to some base value and varies in a certain pattern. This pattern is designed by using statistical methods to yield the most information by a minimum number of experiments. In this study we adopt RSM approach to locate the optimum levels of Glutamine, EAA (Essential Amino Acids), NEAA (Non Essential Amino Acids), ITS (Insulin, Transferrin, Selenium,), Lipids, to gain an insight of interactions among these factors which were expected to have major influence on the response viable cell density. Glutamine acts as the primary source of nitrogen as well as additional carbon and energy source.
It contributes precursors to the formation of the major intracellular binding blocks: amino acids, proteins. It has been estimated that between 30 to 65% of the cell energy requirement is derived from glutamine metabolism (21, 22) .
Amino acids are primary sources of nitrogen and they protect cells from nutrient deprivation (23) and elevated osmolarity (24) and elevated pCO 2 (25) . Insulin serves as growth and maintenance factor (26) and is considered to be important for serum free cultures. The functions include stimulation of uridine and glucose uptake, and synthesis of RNA, protein and lipid, increases fatty acid and glycogen synthesis (27) . Transferrin is considered one of the most essential growth promoting supplements in serum free media and its omission has led to severe inhibition of cell growth (28) . It is iron binding glycoprotein, interacts with surface receptors and has an intimate role in the facilitation of the iron transport across the plasma membrane (29) . It has additional in vitro functions such as chelation of deleterious trace materials, these functions are unlikely replaced by other components. Selenium is a trace element essential for mammalian cell cultures (30) mechanism is poorly understood. There was evidence that selenium enhances growth rate in serum free cultures (31) . Lipids are required for proliferation, differentiation, and antibody secretion. They play a major role in the cell membrane which is composed of phospo-lipid bi-layer, and helps in the transmission of nutrients into the cell and excretion of proteins out the cell (32) . These major important functions exhibited by the variables made us to choose the response surface methodology to see the higher order interactions between these variables maximizing the response. Results were analyzed statistically by SAS program and optimum conditions were selected graphically. Interactions among these factors were also examined.
Materials and Methods
Cell Line and Media
The parental cell line was obtained by weaning CHO-DG44 off of serum according to standard cell culture techniques. The base medium used during the weaning process was commercial serum free medium CHO-S-SFMII, known to contain animal-derived proteins and hydrolysates. The process of weaning CHO-DG44 of its serum dependence lasted approximately 4-5 months. And the resulting cell line was used as the starting point for all subsequent development efforts including recombinant cell line generation, medium development studies.
Recombinant cell lines were derived from our parent cell line using standard molecular biology techniques.
Media
The 
Cell Culture
The cell cultivation was performed in 37 0 C humidified incubators supplemented with 5% carbon dioxide.
The seeding density was 2*10 5 cells/ml, and cell counts were performed every four days. The number of cells was determined using a hemocytometer. Spheroids would be enzymatically dissociated when spherical aggregates were observed. Two ml of sample was harvested from spinners and placed in 1.7 ml microtube and centrifuged at 1200 rpm for six minutes, and 1.5 ml supernatant was saved for antibody assays, 100 µl of trypsin solution (2.5% (w/v) Trypsin in PBS) was added to resuspend the cells of 400 µl. The cells were incubated at room temperature for fifteen minutes and the cell density and viability were then determined by then trypan blue exclusion method.
Antibody Assay
The concentration of the whole antibody, as well as the concentration of the light and heavy chain portions was determined by an enzyme-linked immunosorbent assay. Affinity purified rabbit anti-human IgG antibodies were diluted to 5 µg/ml in coating buffer consisting of 100 mM NaHCO 3 and 100 mM NaCl (pH = 9.3). 100 µl diluted antibody was added to 96 well plates (Nunc) and incubated overnight at 4 o C. The plates were washed twice in Tris buffer (20 mM Tris-HCl, 50 mM NaCl, pH = 7.2) containing 0.1% Tween 20 and then twice in Tris buffer alone. Blocking buffer (Tris buffer with 0.5% BSA) was added to the 96 well plates and incubated at 37 o C for 1 h.
Supernatant samples were diluted in the blocking buffer and samples were loaded into the 96 well plates in triplicate.
Plates were incubated for 1 h at 37 o C and the washing procedure was repeated. 100 µl of a goat anti-human IgG-HRP conjugate antibody diluted to 0.5 to 2 mg/ml in the dilution buffer was added to the plates. The plates were incubated for 1 h at 37 o C and the washing procedure was repeated. Lastly, 100 ml of 50 µg/ml ABTS in ABTS buffer (Roche) was added to the plates. The absorbance was determined at 405 nm using a ELx800 plate reader (Bio-Tek). This procedure was used for whole antibody, heavy chain (Fc specific), and light chain (κ specific).
Whole, Fc and kappa rabbit anti-human IgG coating antibodies and whole, Fc and kappa goat anti-human IgG-HRP conjugated antibodies were used in the ELISAs (Sigma).
Experimental Design
Response surface methodology (RSM) was used to determine the influence of some medium components on the response of viable cell density and since we assume our product is growth-associated product, increase in viable cell density will ultimately increase the antibody production. Theoretical and fundamental aspects of RSM have been extensively discussed else where (16) . The experimental design adopted Box's central composite design
for five variables at five levels each. The five independent variables were X1 = Glutamine, X2 = EAA, X3 = NEAA, X4 = ITS, X5 = Lipids. The independent variable coded regions were -α (-2, Lowest Level), -1, 0 (middle level), I, and +α (2, highest level). The actual values, which were chosen from preliminary studies, and the corresponding coded and uncoded values of the five independent variables are given in Table 2 . The complete design has 42 experimental points, which included 8 replications of the center point. The treatment combinations and observed responses are presented Table 3 . The 50 experimental media runs were prepared in random order and the experiments were performed in four batches. The dependent variable (Y) was viable cell density and was assumed to be affected by the five independent variables. Based on data from this design we fit a second order or higher order polynomial regression model described as follows: 
Statistical Analysis
Using ordinary least squares the regression model was fit to evaluate, the explanatory variables regarding linear, interaction, and quadratic effects of coded levels of Glutamine, EAA, NEAA, ITS, Lipids on cell density. The R 2 value was used to evaluate model sufficiency and the α-level was set as 5% at which every term in the selected model should be significant. The reduced model was evaluated using the R 2 and lack of fit and was used to attempt to find optimal conditions for all the variables maximizing the cell density. Canonical analysis was then used to evaluate the nature of the stationary point (maximum, minimum or saddle) and to find the ridge of steepest ascent.
Further experiments were carried out in the direction of the maximum response along with alternate experiments where Glutamine was set to different coded levels from '0' to '-3', keeping EAA constant at coded level '2' and '4'.
All statistical computations were done using SAS/STAT procedures, optimum conditions were found through SAS data-step programming. Response surface plots were generated by SAS/GRAPH
Results and Discussion
Regression analysis revealed that linear and quadratic effects were more significant than cross product interactions (Table 4) . Among all the independent variables, Glutamine (negative effect) and NEAA (positive effect)
had the greatest effects on the cell density, while EAA showed an effect when combined with Glutamine. Among the pair wise interactions EAA and Glutamine exhibited the greatest effect. NEAA squared and NEAA by itself were significant but when compared with the other variables did not showed great effect. The response surface plots are plotted to see the effect of EAA and NEAA (Fig. 1 ), EAA and Glutamine (Fig. 2 ), NEAA and Glutamine (Fig. 3 ) on the response which is viable cell density (Y). ITS and Lipids didn't have effects in anyway. The R 2 value for the total model is 0.6339. To simplify the model, the variables ITS and Lipids were removed from the model and the data were re-analyzed using the reduced model. The polynomial regression model used for three variables was
When the variables ITS and Lipids kept constant, the lack of fit is insignificant suggesting that model is adequate to explain the effect of these three variables on the response. The R 2 value of the reduced model decreases to 0.502. From the Table 5 , still the Glutamine had significant linear effects and interacted with EAA, EAA and NEAA had significant quadratic effects while NEAA also had a linear effect on the cell density.
Canonical Analysis:
Canonical analysis is a mathematical approach used to examine the overall shape of the response surface and to determine if the estimated response point is a maximum, minimum or a saddle point. If the stationary point is maximum or minimum, a corresponding increase or decrease will result in the response, and in the case of saddle point then we may get an increase or decrease in the response when we move away from the stationary point, depending on which direction to be taken to get the maximum or minimum response. The maximization the viable cell density is of interest; however the stationary point was a saddle point, so we move on the ridge in the direction to get maximum response. Points on the ridge that increased the response were found using the RIDGEMAX option of the SAS/RSREG procedure and are as shown in the Table 6 .
From the Table 5 and 6, glutamine showed a negative effect on cell density while EAA, NEAA showed a positive effect, so the Glutmine values for the ridge moved in the negative direction and in the positive direction for the variables EAA and NEAA. Following the ridge in Table 6 the highest cell density was 1.37E+06 cells/ml, but this prediction was not very reliable due to large standard error. Based on the ridge analysis, the Glutamine that had high cell densities were decreasing below 1 mM. We felt Glutamine values smaller than 1 mM were not reasonable and we were about conducting further experiments on the ridge below Gln values of 1 mM.
To further explore the surface, we used the reduced model from the Table 6 , and obtained predicted cell densities with Glutamine constant at different coded levels from '0' to '-3', NEAA at '0.5' and various values of EAA. The results are shown in Table 7 , where it suggests that with low glutamine values, the higher values of EAA would increase the cell density. Figure 4 shows the effect of EAA and NEAA on VCD when glutamine is controlled at coded level '-1'.
How ever EAA values up to 14.5 coded level (uncoded value =12.625 X) are biologically not reasonable because of osmotic effects or inhibition of metabolic pathways due to over feeding of the nutrients. But from the above results it is appeared that as Glutamine was lowered and at higher concentrations of EAA and NEAA at 0.5 coded level large cell densities could result
Alternate Experiments:
To further evaluate the surface we ran some alternate experiments at different levels of Glutamine (from coded level '0' to' -3'), keeping EAA constant at coded levels 2 and 4. We expected low cell growth at Glutamine value less than '-1.5 coded level' and no cell growth at Zero ('-2' coded level) glutamine concentration. We also expected the EAA coded level at '2' to result in higher cell densities compared to EAA coded level 4, because of osmotic effects and the inhibition of metabolic pathways due to over-feeding. Therefore 14 more experiments were carried out, four being on the ridge, four being at different level of Glutamine keeping EAA at coded 2, four being at EAA coded level 4, and two controls (Basal media) as shown in Table 8 .
These experiments were with all other conditions the same as the initial experiments. The starting density of the cultures was 2*10 5 cells/ml, and the cells were allowed to adapt to the media in four passages. The final viable cell densities are mentioned as average of the third and the fourth passage, as shown in Table 8 .
The Media-6 had a higher cell density compared to the controls (13 and 14) , but the last passage of the media's 3, 9, and 5 were nearly equal to the control media, shown in Fig 5. So, these media's, which were doing, better than (or equal to) Media-0, were carried out for one more passage (up to 8 days), to confirm their results. The results are shown in Figure 6 . From the passage 5, the viable cell density attained in the media 6 after 5 days is about 1.6 times more than the control.
Replicate Experiments
The Media-6 resulted in higher cell densities than the control media, but to confirm the results, the cells in the control media were taken out of frozen, and the experiment was repeated three times with control media and Media-6. Cells were allowed to go for four passages and the final viable cell densities are taken as average of passage 3 and passage 4, the results are given in Figure 7 .
So, for media-6 the viable cell density averaged over the replicates attained 1.45 * 10 6 cells/ml, which is 1.4 times more than the control media and within two standard errors of 1.23E+06 from the original run of media 6 (se = 215928 cells/ml for media 6). After four passages if the cells were allowed to grow to passages of 5 to 7 the viable cell density increased to 1.6* 10 6 cells/ml. The viable cell density on the control experiment in these passages (Passages 5 to 7) was between 9.2*106 cells/ml to 1.1 *10 6 cells/ml, with in the standard deviation of 128103 cells/ml (data not shown).
Assuming the antibody production depends on the cell density, we should see an increase in the antibody production with the increase in cell density. The production is determined and standard deviation is calculated in these media's from triplicate experiments. The results are given in Figure 8 . The production is determined for all the initial 50 media experiments, and the results were analyzed using SAS/STAT procedures. We saw the same trend for production also where the stationary point is a saddle point, and the ridge values for the glutamine are moving in the negative direction and in positive direction for EAA and NEAA, shown in Table 9 . The R 2 value for the model was 0.75 which shows adequacy of the model in explaining the effect of the variables on the response which is antibody production.
So the antibody production in the Media -6 was 1.6 times more than the control Media. So the Composition of the variables in the best Media -6 is Table 10 .
Conclusions
The increase in the viable cell density (Cells/ml), and the production of the antibody against BoNT-A was accomplished by using Box-Wilson's Central Composite Design. The viable cell density is increased by 1.4 times and the antibody production increased by 1.6 times. The lower values of the Glutamine and higher values of EAA are preferred. From the results it is expected that one of the amino acids is replacing the role of amino acidGlutamine, and may be acting as limiting nutrient. So doing amino acid analysis, that limiting amino acid can be found, and if it is added separately, then we can decrease the concentration of the total amino acid, by that way we can make the media more economical and may also get higher cell densities and antibody production. Table 11 : Concentrations of the five variables of the optimal media, (total concentration of all amino acids in EAA and NEAA are given in g/L). Concentration of the remaining components same as given in Table 1 
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